Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment

Age and Ageing

Volumn 34, Issue 1, 2005, Pages 1-3

  Lane, Deirdre ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTICOAGULANT AGENT; THROMBIN INHIBITOR; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ALCOHOL ABSTINENCE; ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; COGNITION; CONFIDENCE INTERVAL; DIET; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG METABOLISM; DRUG MONITORING; DRUG PREFERENCE; EDITORIAL; ELDERLY CARE; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; STROKE; THROMBOEMBOLISM;

AGE FACTORS; AGED; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; WARFARIN;

EID: 12144264059     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afi008     Document Type: Editorial

References (28)

1. Freestone B, Lip GYH. Epidemiology and costs of cardiac arrhythmias. In Lip GYH, Godtfredsen J. (eds) Cardiac Arrhythmias: a clinical approach. Edinburgh: Mosby 2003; 3-24.
2. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501.
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction, and stroke in highrisk patients. BMJ 2002; 324: 71-86.
4. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Ann Intern Med 1999; 131: 927-34.
5. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998; 97: 1231-3.
6. Mendelson G, Aronow WS. Under-utilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc 1998; 46: 1423-4.
7. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-71.
8. Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and anti-platelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991; 151: 1950-3.
9. Fihn SD, Callahan CM, Martin DC, McDonnell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 1996; 124: 970-9.
10. Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc 1997; 45: 1060-5.
11. Lip GYH, Zarifis J, Watson RDS, Beevers DG. Physician variation in the management of patients with atrial fibrillation. Heart 1996; 75: 200-5.
12. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155: 277-81.
13. Williams E, Ansari M, Lip GYH. Managing atrial fibrillation in the Accident and Emergency Department. QJM 2001; 94: 609-14.
14. Lip GYH, Kamath S, Jafri M, Mohammed A, Bareford D. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke 2002; 33: 238-42.
15. Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study. Age Ageing 2004; 34: 35-40.
16. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 1994; 343: 687-91.
17. Mant JW, Richards SH, Hobbs FR et al. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. BMC Cardiovasc Disord 2003; Aug 26; 3: 9.
18. Department of Health. Patient and public involvement in the new NHS. London: Department of Health, 1999.
19. Morris J, Royle GT. Offering patients a choice of surgery for early breast cancer: a reduction in anxiety and depression in patients and their husbands. Soc Sci Med 1988; 26: 584-5.
20. Bertakis KD. The communication of information from physician to patient: a method for increasing patient retention and satisfaction. J Family Pract 1997; 5: 217-22.
21. Roter DL, Hall JA, Merisca R et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998; 36: 1138-61.
22. Kaplan S, Greenfield S, Ware JE. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 1989; 27: S110-27.
23. Howitt A, Armstrong D. Implementing evidence-based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ 1999; 318: 1324-7.
24. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000; 160: 41-6.
25. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis. BMJ 2000; 320: 1380-4.
26. Fuller R, Dudley N, Blacktop J. Risk communication and older people - understanding of probability and risk information by medical inpatients aged 75 years and older. Age Ageing 2001; 30: 473-6.
27. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation-semi qualitative analysis of older patients' views about stroke prevention and the use of warfarin. Age Ageing 2004; 33: 608-11.
28. Hamaad A, Tayebjee MH, Lip GYH. Ximelagatran: the future in anticoagulation practice? Br J Cardiol 2004; 11: 229-34.